{
    "clinical_study": {
        "@rank": "149894", 
        "brief_summary": {
            "textblock": "RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing\n      so they stop growing or die.\n\n      PURPOSE: Phase II trial to study the effectiveness of ISIS 3521 in treating patients who\n      have advanced, unresectable, or metastatic non-small cell lung cancer or unresectable or\n      metastatic melanoma."
        }, 
        "brief_title": "ISIS 3521 in Treating Patients With Advanced, Unresectable, or Metastatic Non-small Cell Lung Cancer or Unresectable or Metastatic Melanoma", 
        "condition": [
            "Lung Cancer", 
            "Melanoma (Skin)"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Carcinoma, Non-Small-Cell Lung", 
                "Lung Neoplasms", 
                "Melanoma"
            ]
        }, 
        "detailed_description": {
            "textblock": "OBJECTIVES: I. Determine the complete and partial response rates and duration of response in\n      patients with locally advanced, unresectable, or metastatic non-small cell lung cancer or\n      unresectable or metastatic melanoma treated with ISIS 3521. II. Determine safety of ISIS\n      3521 in these patients.\n\n      OUTLINE: This is a multicenter study. Patients are stratified by disease type. Patients\n      receive ISIS 3521 IV over 21 days followed by 7 days of rest. Courses repeat every 28 days\n      in the absence of disease progression or unacceptable toxicity.\n\n      PROJECTED ACCRUAL: A total of 28-50 patients (14-25 per stratum) will be accrued for this\n      study."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "DISEASE CHARACTERISTICS: Histologically or cytologically proven melanoma that is\n        unresectable and regionally metastatic, or widely disseminated OR Histologically or\n        cytologically proven non-small cell lung cancer (NSCLC) that is locally advanced,\n        unresectable, or metastatic Stage IIIA, IIIB, or IV Evidence of disease progression prior\n        to study At least 1 bidimensionally measurable lesion The following are NOT considered\n        measurable: previously irradiated lesions, ascites, pleural effusion, bone metastases,\n        brain metastases, leptomeningeal disease, or an abdominal mass that can be palpated but\n        not measured Melanoma patients whose only manifestation of disease is 1 of the following\n        are NOT eligible: Lymphedema Pleural effusion Ascites CNS metastases Bone marrow\n        infiltration Osteoblastic bone lesions\n\n        PATIENT CHARACTERISTICS: Age: 18 and over Performance status: WHO 0-2 Life expectancy: At\n        least 3 months Hematopoietic: Neutrophil count at least 1,500/mm3 Platelet count at least\n        100,000/mm3 No abnormal clotting tests Hepatic: Bilirubin no greater than 2.0 mg/dL AST\n        and ALT no greater than 2 times upper limit of normal (ULN) (5 times ULN if due to liver\n        metastases) Renal: Creatinine no greater than 1.6 mg/dL OR Creatinine clearance at least\n        60 mL/min Urinary protein less than 0.3 g/dL Cardiovascular: No superior vena cava\n        obstruction in NSCLC unless successfully treated at least 2 months prior to study Other:\n        No underlying disease state associated with active bleeding No prior or concurrent\n        malignancies at other sites except adequately treated cone biopsied carcinoma in situ of\n        the cervix uteri or basal cell or squamous cell skin cancer No nonmalignant systemic\n        disease making patient poor risk for study No active uncontrolled infection Not pregnant\n        or nursing Negative pregnancy test Fertile patients must use effective contraception\n        during and for 3 weeks after study\n\n        PRIOR CONCURRENT THERAPY: Biologic therapy: At least 4 weeks since prior immunotherapy\n        (including interferon or interleukin-2) for melanoma patients No other concurrent\n        anticancer immunotherapy Chemotherapy: No prior chemotherapy for melanoma patients except\n        adjuvant or local chemotherapy (extracorporeal circulation) At least 4 weeks since prior\n        adjuvant or local chemotherapy if presence of measurable lesions outside the treated limb\n        (6 months if no presence of measurable lesions outside the treated limb) No prior\n        chemotherapy for NSCLC except platinum compounds used as radiosensitizer At least 4 weeks\n        since prior platinum compounds No other concurrent anticancer chemotherapy Endocrine\n        therapy: Not specified Radiotherapy: At least 4 weeks since prior radiotherapy Concurrent\n        radiotherapy allowed for bone pain or other reasons No irradiation of all evaluable\n        lesions Surgery: See Disease Characteristics Other: At least 4 weeks since other prior\n        investigational drugs No other concurrent investigational drugs No concurrent\n        anticoagulants except heparin used to prevent occlusion of IV lines during week(s) off\n        treatment"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 1, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00003989", 
            "org_study_id": "EORTC-16977", 
            "secondary_id": [
                "EORTC-16977", 
                "ISIS-EORTC-16977"
            ]
        }, 
        "intervention": {
            "intervention_name": "ISIS 3521", 
            "intervention_type": "Biological"
        }, 
        "keyword": [
            "recurrent non-small cell lung cancer", 
            "stage III melanoma", 
            "stage IV melanoma", 
            "recurrent melanoma", 
            "stage IIIA non-small cell lung cancer", 
            "stage IIIB non-small cell lung cancer", 
            "stage IV non-small cell lung cancer"
        ], 
        "lastchanged_date": "July 10, 2012", 
        "link": {
            "description": "Clinical trial summary from the National Cancer Institute's PDQ\u00ae database", 
            "url": "http://cancer.gov/clinicaltrials/EORTC-16977"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Innsbruck", 
                        "country": "Austria", 
                        "zip": "A-6020"
                    }, 
                    "name": "Universitaetsklinik"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Vienna (Wien)", 
                        "country": "Austria", 
                        "zip": "A-1100"
                    }, 
                    "name": "Kaiser Franz Josef Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brussels (Bruxelles)", 
                        "country": "Belgium", 
                        "zip": "1000"
                    }, 
                    "name": "Institut Jules Bordet"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brussels (Bruxelles)", 
                        "country": "Belgium", 
                        "zip": "B-1200"
                    }, 
                    "name": "Ludwig Institute for Cancer Research-Brussels Branch"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Edegem", 
                        "country": "Belgium", 
                        "zip": "B-2650"
                    }, 
                    "name": "Universitair Ziekenhuis Antwerpen"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Leuven", 
                        "country": "Belgium", 
                        "zip": "B-3000"
                    }, 
                    "name": "U.Z. Gasthuisberg"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Herlev", 
                        "country": "Denmark", 
                        "zip": "DK-2730"
                    }, 
                    "name": "Herlev Hospital - University Hospital of Copenhagen"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Clermont-Ferrand", 
                        "country": "France", 
                        "zip": "63011"
                    }, 
                    "name": "Centre Jean Perrin"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lyon", 
                        "country": "France", 
                        "zip": "69373"
                    }, 
                    "name": "Centre Leon Berard"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nantes-Saint Herblain", 
                        "country": "France", 
                        "zip": "44805"
                    }, 
                    "name": "CRLCC Nantes - Atlantique"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Toulouse", 
                        "country": "France", 
                        "zip": "31052"
                    }, 
                    "name": "Institut Claudius Regaud"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Villejuif", 
                        "country": "France", 
                        "zip": "F-94805"
                    }, 
                    "name": "Institut Gustave Roussy"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Essen", 
                        "country": "Germany", 
                        "zip": "D-45122"
                    }, 
                    "name": "Universitaetsklinik und Strahlenklinik - Essen"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nuremberg (Nurnberg)", 
                        "country": "Germany", 
                        "zip": "D-90419"
                    }, 
                    "name": "Klinikum Nurnberg"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Amsterdam", 
                        "country": "Netherlands", 
                        "zip": "1007 MB"
                    }, 
                    "name": "Academisch Ziekenhuis der Vrije Universiteit"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Amsterdam", 
                        "country": "Netherlands", 
                        "zip": "1066 CX"
                    }, 
                    "name": "Antoni van Leeuwenhoekhuis"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Groningen", 
                        "country": "Netherlands", 
                        "zip": "9713 EZ"
                    }, 
                    "name": "Academisch Ziekenhuis Groningen"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nijmegen", 
                        "country": "Netherlands", 
                        "zip": "6500 HB"
                    }, 
                    "name": "St. Radboud University Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rotterdam", 
                        "country": "Netherlands", 
                        "zip": "3075 EA"
                    }, 
                    "name": "Rotterdam Cancer Institute"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Oslo", 
                        "country": "Norway", 
                        "zip": "N-0310"
                    }, 
                    "name": "Norwegian Radium Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Basel", 
                        "country": "Switzerland", 
                        "zip": "CH-4031"
                    }, 
                    "name": "University Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bern", 
                        "country": "Switzerland", 
                        "zip": "CH-3010"
                    }, 
                    "name": "Inselspital, Bern"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Saint Gallen", 
                        "country": "Switzerland", 
                        "zip": "CH-9007"
                    }, 
                    "name": "Kantonsspital - Saint Gallen"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Newcastle Upon Tyne", 
                        "country": "United Kingdom", 
                        "state": "England", 
                        "zip": "NE4 6BE"
                    }, 
                    "name": "Newcastle General Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dundee", 
                        "country": "United Kingdom", 
                        "state": "Scotland", 
                        "zip": "DD1 9SY"
                    }, 
                    "name": "Ninewells Hospital and Medical School"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Edinburgh", 
                        "country": "United Kingdom", 
                        "state": "Scotland", 
                        "zip": "EH4 9NQ"
                    }, 
                    "name": "Western General Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Glasgow", 
                        "country": "United Kingdom", 
                        "state": "Scotland", 
                        "zip": "G61 1BD"
                    }, 
                    "name": "C.R.C. Beatson Laboratories"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "Austria", 
                "Belgium", 
                "Denmark", 
                "France", 
                "Germany", 
                "Netherlands", 
                "Norway", 
                "Switzerland", 
                "United Kingdom"
            ]
        }, 
        "official_title": "Phase II Trial With ISIS 3521/CGP 64128A in Patients With Malignant Melanoma and Non Small Cell Lung Cancer", 
        "overall_official": {
            "affiliation": "Universitaetsspital-Basel", 
            "last_name": "Shoshana Kaplan, MD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 2", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00003989"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "European Organisation for Research and Treatment of Cancer - EORTC", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "European Organisation for Research and Treatment of Cancer - EORTC", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 1998", 
        "study_design": "Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2012"
    }, 
    "geocoordinates": {
        "Academisch Ziekenhuis Groningen": "53.219 6.567", 
        "Academisch Ziekenhuis der Vrije Universiteit": "52.37 4.895", 
        "Antoni van Leeuwenhoekhuis": "52.37 4.895", 
        "C.R.C. Beatson Laboratories": "55.864 -4.252", 
        "CRLCC Nantes - Atlantique": "47.21 -1.602", 
        "Centre Jean Perrin": "45.777 3.087", 
        "Centre Leon Berard": "45.764 4.836", 
        "Herlev Hospital - University Hospital of Copenhagen": "55.73 12.425", 
        "Inselspital, Bern": "46.948 7.445", 
        "Institut Claudius Regaud": "43.605 1.444", 
        "Institut Gustave Roussy": "48.793 2.359", 
        "Institut Jules Bordet": "50.85 4.352", 
        "Kaiser Franz Josef Hospital": "48.208 16.374", 
        "Kantonsspital - Saint Gallen": "47.424 9.371", 
        "Klinikum Nurnberg": "49.499 11.078", 
        "Ludwig Institute for Cancer Research-Brussels Branch": "50.85 4.352", 
        "Newcastle General Hospital": "54.978 -1.618", 
        "Ninewells Hospital and Medical School": "56.462 -2.971", 
        "Norwegian Radium Hospital": "59.914 10.752", 
        "Rotterdam Cancer Institute": "51.924 4.482", 
        "St. Radboud University Hospital": "51.843 5.855", 
        "U.Z. Gasthuisberg": "50.878 4.704", 
        "Universitaetsklinik": "47.269 11.404", 
        "Universitaetsklinik und Strahlenklinik - Essen": "51.462 7.009", 
        "Universitair Ziekenhuis Antwerpen": "51.153 4.438", 
        "University Hospital": "47.557 7.593", 
        "Western General Hospital": "55.953 -3.188"
    }
}